Daily Aspirin Cuts Colorectal Cancer in High-Risk Adults (CME/CE, with audio)

(MedPage Today) — Chemoprevention with aspirin cut development of colorectal cancer by 60% in patients at high risk for the disease because of a genetic defect, according to results of a randomized, placebo-controlled trial.

Post a Comment

Comments are closed.